Cargando…

Ischemic Cholangiopathy Postdonation After Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters

BACKGROUND. Outcomes of liver transplantation (LT) from donation after circulatory death (DCD) have been improving; however, ischemic cholangiopathy (IC) continues to be a problem. In 2014, measures to minimize donor hepatectomy time (DHT) and cold ischemic time (CIT) have been adopted to improve DC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goussous, Naeem, Alvarez-Casas, Josue, Dawany, Noor, Xie, Wen, Malik, Saad, Gray, Stephen H., Barth, Rolf N., LaMattina, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Liver Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710320/ https://www.ncbi.nlm.nih.gov/pubmed/34966844 http://dx.doi.org/10.1097/TXD.0000000000001277

Ejemplares similares

Acute on Chronic Liver Failure: Factors Associated With Transplantation
por: Goussous, Naeem, et al.
Publicado: (2021)

Survival Outcomes Are Not Affected When Liver Transplant Surgery Is Done at Night, During Weekends, or Summer Months
por: Thuluvath, Paul J., et al.
Publicado: (2019)

Insights Into the Experience of Liver Transplant Recipients With Alcoholic Liver Disease: A Descriptive Qualitative Study
por: Hochheimer, Martin, et al.
Publicado: (2019)

Rapid Metabolic Recovery of Donor Circulatory Death Liver Graft Using Whole Blood Perfusion: A Pig Study
por: Yoshimoto, Syuhei, et al.
Publicado: (2021)

Safely Implementing a Program of Pure Laparoscopic Donor Right Hepatectomy: The Experience From a Southeast Asian Center
por: Law, Jia-Hao, et al.
Publicado: (2023)

Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
por: Mazilescu, Laura Ioana, et al.
Publicado: (2021)

The Implications of the Shift Toward Donation After Circulatory Death in Australia
por: Reiling, Janske, et al.
Publicado: (2017)

Donor-derived Cell-free DNA in Infections in Kidney Transplant Recipients: Case Series
por: Goussous, Naeem, et al.
Publicado: (2020)

Machine Perfusion of Donation After Circulatory Death Liver and Lungs Before Combined Liver-lung Transplantation
por: van Leeuwen, Otto B., et al.
Publicado: (2021)

Donor BMI and Post–living Donor Liver Transplantation Outcomes: A Preliminary Report
por: Lin, Jessica S., et al.
Publicado: (2023)

The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors
por: Hidaka, Masaaki, et al.
Publicado: (2016)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
por: Imamura, Hajime, et al.
Publicado: (2017)

Kidney Donor Profile Index Is a Reliable Alternative to Liver Donor Risk Index in Quantifying Graft Quality in Liver Transplantation
por: Scheuermann, Uwe, et al.
Publicado: (2019)

Liver Transplantation With Grafts From Super Obese Donors
por: Vargas, Paola A., et al.
Publicado: (2021)

First Experience in Living Liver Donation From Donors With Sickle Cell Trait
por: Schulze, Maren, et al.
Publicado: (2022)

Management of Ascites Following Deceased Donor Liver Transplantation: A Case Series
por: Al-Zoubi, Mohammad, et al.
Publicado: (2022)

Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated With Improved Postreperfusion Hemodynamics
por: Angelico, Roberta, et al.
Publicado: (2016)

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

Outcomes in Adult Liver Transplant Recipients Using Pediatric Deceased Donor Liver Grafts
por: Vargas, Paola A., et al.
Publicado: (2022)

Transplant of SARS-CoV-2–infected Living Donor Liver: Case Report
por: Nguyen, Michelle C., et al.
Publicado: (2021)

Steroid Avoidance After Adult Living Donor Liver Transplant: A Cohort Analysis
por: Nunez, Miguel, et al.
Publicado: (2023)

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience
por: Barbas, Andrew S., et al.
Publicado: (2017)

Living Donor Liver Transplantation Using a Liver Graft With Congenital Intrahepatic Portosystemic Shunt
por: Kamei, Hideya, et al.
Publicado: (2015)

Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver Failure
por: Kitajima, Toshihiro, et al.
Publicado: (2022)

Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience
por: Miura, Kohei, et al.
Publicado: (2018)

A Novel Surgical Technique to Assure Donor and Recipient Safety: Pyloric to Segment 4 Arterial Reconstruction
por: Fraile, Andres, et al.
Publicado: (2020)

A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation
por: Steggerda, Justin A., et al.
Publicado: (2022)

Is a Preservation Solution for Living Donor Liver Transplantation Needed? Adding a New Chapter in LDLT!
por: Dogar, Abdul Wahab, et al.
Publicado: (2022)

Risk Factors for Intractable Ascites After Adult-to-Adult Living Donor Liver Transplantation Using Left Lobe
por: Matsudaira, Shinichi, et al.
Publicado: (2017)

Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation
por: Brüggenwirth, Isabel M.A., et al.
Publicado: (2017)

Reexamining Risk Aversion: Willingness to Pursue and Utilize Nonideal Donor Livers Among US Donation Service Areas
por: Halpern, Samantha E., et al.
Publicado: (2021)

Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey
por: Akamatsu, Nobuhisa, et al.
Publicado: (2021)

Endothelial Dysfunction in Steatotic Human Donor Livers: A Pilot Study of the Underlying Mechanism During Subnormothermic Machine Perfusion
por: Beijert, Irene, et al.
Publicado: (2018)

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation
por: Lentine, Krista L., et al.
Publicado: (2019)

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients
por: Engels, Eric A., et al.
Publicado: (2018)

Outcomes of Living Donor Liver Transplantation Alone for Patients on Maintenance Renal Replacement Therapy in Japan: Results of a Nationwide Survey
por: Eguchi, Susumu, et al.
Publicado: (2016)

Biliary Complications Following Adult Deceased Donor Liver Transplantation: Risk Factors and Implications at a High-volume US Center
por: Matar, Abraham J., et al.
Publicado: (2021)

Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant Recipients
por: Echeverri, Juan, et al.
Publicado: (2017)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
por: Goh, Su Kah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3cnlaa6ajd1est68qhda87ebe4